Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Koh

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Journal of Medicinal Chemistry|April 18, 2003
Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strainsHirokazu Tamamura, Yasuhiro Koh, Satoshi Ueda, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Drastic initial response and subsequent response to two ALK inhibitors in a patient with a highly aggressive ALK-rearranged inflammatory myofibroblastic tumor arising in the pleural cavityAkira Ono, Haruyasu Murakami, Masakuni Serizawa, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2007
A novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065, is potent against multiple-PI-resistant human immunodeficiency virus in vitroMasayuki Amano, Yasuhiro Koh, Debananda Das, et al.
Clinical Lung Cancer|April 22, 2019
Heterogeneous Expression of Programmed Death Receptor-ligand 1 on Circulating Tumor Cells in Patients With Lung CancerYasuhiro Koh, Satomi Yagi, Hiroaki Akamatsu, et al.
Cancer Science|December 29, 2015
Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating tumor cellsTakeshi Sawada, Masaru Watanabe, Yuu Fujimura, et al.
Cancer Diagnosis & Prognosis|May 5, 2025
Relationship Between T790M Allele Frequency and Therapeutic Effects Before and After EGFR-TKI Administration Using Droplet Digital PCR in Non-small-cell Lung Cancer With EGFR MutationKoichi Ogawa, Hiroyasu Kaneda, Yasuhiro Koh, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2015
Progression of Irreversible Airflow Limitation in Asthma: Correlation with Severe ExacerbationsKazuto Matsunaga, Tsunahiko Hirano, Asako Oka, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumabJun Oyanagi, Yasuhiro Koh, Koichi Sato, et al.
The Journal of Biological Chemistry|July 20, 2007
Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerizationYasuhiro Koh, Shintaro Matsumi, Debananda Das, et al.
JTO Clinical and Research Reports|April 9, 2026
Atezolizumab Combined With Cisplatin Plus Vinorelbine as Adjuvant Therapy for Completely Resected NSCLC With <i>EGFR</i> Mutation (West Japan Oncology Group 11719L: ADJUST Study)Ryota Shibaki, Hiroaki Akamatsu, Morihito Okada, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Journal of Medicinal Chemistry|April 18, 2003
Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strainsHirokazu Tamamura, Yasuhiro Koh, Satoshi Ueda, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Drastic initial response and subsequent response to two ALK inhibitors in a patient with a highly aggressive ALK-rearranged inflammatory myofibroblastic tumor arising in the pleural cavityAkira Ono, Haruyasu Murakami, Masakuni Serizawa, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2007
A novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065, is potent against multiple-PI-resistant human immunodeficiency virus in vitroMasayuki Amano, Yasuhiro Koh, Debananda Das, et al.
Clinical Lung Cancer|April 22, 2019
Heterogeneous Expression of Programmed Death Receptor-ligand 1 on Circulating Tumor Cells in Patients With Lung CancerYasuhiro Koh, Satomi Yagi, Hiroaki Akamatsu, et al.
Cancer Science|December 29, 2015
Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating tumor cellsTakeshi Sawada, Masaru Watanabe, Yuu Fujimura, et al.
Cancer Diagnosis & Prognosis|May 5, 2025
Relationship Between T790M Allele Frequency and Therapeutic Effects Before and After EGFR-TKI Administration Using Droplet Digital PCR in Non-small-cell Lung Cancer With EGFR MutationKoichi Ogawa, Hiroyasu Kaneda, Yasuhiro Koh, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2015
Progression of Irreversible Airflow Limitation in Asthma: Correlation with Severe ExacerbationsKazuto Matsunaga, Tsunahiko Hirano, Asako Oka, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumabJun Oyanagi, Yasuhiro Koh, Koichi Sato, et al.
The Journal of Biological Chemistry|July 20, 2007
Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerizationYasuhiro Koh, Shintaro Matsumi, Debananda Das, et al.
JTO Clinical and Research Reports|April 9, 2026
Atezolizumab Combined With Cisplatin Plus Vinorelbine as Adjuvant Therapy for Completely Resected NSCLC With <i>EGFR</i> Mutation (West Japan Oncology Group 11719L: ADJUST Study)Ryota Shibaki, Hiroaki Akamatsu, Morihito Okada, et al.
Pageof 15